These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3163908)

  • 21. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
    Byun JH; Kim M; Lee Y; Lee K; Chong Y
    Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.
    Ohm-Smith MJ; Sweet RL
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1434-7. PubMed ID: 3479048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
    Aldridge KE; Henderberg A; Sanders CV
    J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
    Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
    Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
    Henderson G; Garner J; Morris A
    N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
    Lee K; Chong Y; Jeong SH; Xu XS; Kwon OH
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.
    Wexler HM; Finegold SM
    Antimicrob Agents Chemother; 1988 Mar; 32(3):403-6. PubMed ID: 3364960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal activity of ceftizoxime, cefotetan, and clindamycin against cefoxitin-resistant strains of the Bacteroides fragilis group.
    Aldridge KE; Stratton CW
    J Antimicrob Chemother; 1991 Nov; 28(5):701-5. PubMed ID: 1778873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of susceptibility of anaerobic bacteria to cefotetan and cefoxitin by the thioglycolate disk elution method.
    Barry AL; Packer RR
    J Clin Microbiol; 1984 Nov; 20(5):912-6. PubMed ID: 6595259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.
    Kays MB; White RL; Friedrich LV; Del Bene VE
    Clin Ther; 1991; 13(5):596-605. PubMed ID: 1799917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro effects of cefotetan on anaerobic bacteria of the genus Bacteroides fragilis group, in comparison with 8 antibiotics].
    Trevisan R; Proietti A; Pitzus E
    G Ital Chemioter; 1985; 32(2):367-70. PubMed ID: 3869115
    [No Abstract]   [Full Text] [Related]  

  • 34. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
    Cáceres M; Carera E; Palmgren AC; Nord CE
    Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefotetan: antimicrobial activity in-vitro compared with that of cefotaxime.
    Dette GA; Knothe H; Henckel S
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():11-7. PubMed ID: 6302064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefotetan: a review of the microbiologic properties and antimicrobial spectrum.
    Jones RN
    Am J Surg; 1988 May; 155(5A):16-23. PubMed ID: 3287964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of cefmetazole against anaerobic bacteria.
    Cornick NA; Jacobus NV; Gorbach SL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2010-2. PubMed ID: 3481541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
    Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes.
    King A; Phillips I
    J Antimicrob Chemother; 1988 Apr; 21(4):425-38. PubMed ID: 3378957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.